Diabetes Studies

 

 

Study To Qualify
Type 2 Diabetes, New Once Weekly Insulin vs. Insulin Degludec, No Placebo Currently Taking Stable Basal Insulin and oral medications with an HBA1c of  6.5 to 10.0.
Type 2 Diabetes, New Once Weekly GLP/GIP agonist vs. Lantus Insulin, No Placebo Currently Taking up to three Oral Diabetic medications with an HBA1c of  7.5 to 10.5.
Type 1 Diabetes, New Bolus Insulin vs. Novolog Insulin, No Placebo Currently Taking Stable Lantus/Toujeo Insulin and Novolog or Humalog with an HBA1c of  6.5 to 10.0.
Type 2 Diabetes, New Once Weekly GLP-1 vs. Placebo On any Diabetic treatment (except GLP-1 & DPP-IV), with A1c between 7.0 and 11 & Cardiovascular risk factors view

 

Comments are closed.